Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2020.12.15
POLL RESULTS OF THE 2020 FOURTH EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 1...
2020.12.09
VOLUNTARY ANNOUNCEMENT THE GROUP'S ENOXAPARIN SODIUM INJECTION OBTAINS APPR...
2020.12.02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2020.11.23
THE COMPANY’S H SHARES WILL BE NEWLY INCLUDED IN THE FTSE GLOBAL EQUITY INDEX SE...
2020.11.23
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
2020.11.23
PROXY FORM FOR THE 2020 FOURTH EXTRAORDINARY GENERAL MEETING TO BE HELD ON TUESD...
2020.11.23
NOTICE OF THE 2020 FOURTH EXTRAORDINARY GENERAL MEETING
2020.11.23
REAPPOINTMENT OF ACCOUNTING FIRMS CREDIT LINE APPLICATION TO CHINA GUANGFA BANK ...
2020.11.23
VOLUNTARY ANNOUNCEMENT - THE COMPANY’S H SHARES WILL BE NEWLY INCLUDED IN THE F...
2020.11.12
VOLUNTARY ANNOUNCEMENT - RESVERLOGIX FILES NEW INTELLECTUAL PROPERTY ON KEY RENA...
第一页
上一页
14
15
16
17
18
下一页
最后一页
